Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$386000.0.

  • Burning Rock Biotech's Cash from Investing Activities rose 2475.63% to -$386000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$893000.0, marking a year-over-year increase of 293.48%. This contributed to the annual value of -$604000.0 for FY2024, which is 5385.79% up from last year.
  • Burning Rock Biotech's Cash from Investing Activities amounted to -$386000.0 in Q3 2025, which was up 2475.63% from -$185000.0 recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Cash from Investing Activities ranged from a high of $44.0 million in Q1 2021 and a low of -$11.2 million during Q3 2021
  • For the 5-year period, Burning Rock Biotech's Cash from Investing Activities averaged around $407842.1, with its median value being -$386000.0 (2025).
  • As far as peak fluctuations go, Burning Rock Biotech's Cash from Investing Activities soared by 14386.89% in 2022, and later crashed by 49677.42% in 2025.
  • Burning Rock Biotech's Cash from Investing Activities (Quarter) stood at -$10.5 million in 2021, then soared by 93.05% to -$730000.0 in 2022, then skyrocketed by 93.7% to -$46000.0 in 2023, then crashed by 141.3% to -$111000.0 in 2024, then crashed by 247.75% to -$386000.0 in 2025.
  • Its Cash from Investing Activities was -$386000.0 in Q3 2025, compared to -$185000.0 in Q2 2025 and -$211000.0 in Q1 2025.